In vitro and in vivo efficacy of lasalocid for treatment of experimental cryptosporidiosis

Veterinary Parasitology

Volumn 90, Issue 4, 2000, Pages 265-270

  Castro Hermida, J A ^a   Freire Santos, F ^a   Oteiza Lopez A M ^a   Vergara Castiblanco, C A ^a   Ares Mazas M E ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Control methods Protozoa; Cryptosporidium parvum; In vitro viability; In vivo infectivity; Lasalocid

Indexed keywords

LASALOCID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DRUG EFFICACY; EXPERIMENTAL INFECTION; INFECTION; MOUSE; NONHUMAN; OOCYST; PROTOZOON;

ANIMALS; ANIMALS, NEWBORN; COCCIDIOSTATS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; FEMALE; FLUORESCENT DYES; INDOLES; INTESTINE, LARGE; INTESTINE, SMALL; LASALOCID; MICE; MICROSCOPY, FLUORESCENCE; MICROSCOPY, PHASE-CONTRAST; PARASITE EGG COUNT; PROPIDIUM; STATISTICS, NONPARAMETRIC;

CRYPTOSPORIDIUM PARVUM; PROTOZOA;

EID: 0034604286     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4017(00)00243-0     Document Type: Article

References (18)

1. Blagburn B.L., Drain K.L., Land T.M., Moore P.H., Kinard R.G., Lindsay D.S., Kumar A., Shi J., Boykin D.W., Tidwell R.R. Dicationic furans inhibit development of Cryptosporidium parvum in HSD/ICR suckling Swiss mice. J. Parasitol. 84(4):1998;851-856.
2. Brasseur P., Lemeteil D., Ballet J.J. Anti-Cryptosporidial drug activity screened with an immunosuppressed rat model. J. Protozool. 38:1991;230-231.
3. Brasseur P., Favennec L., Leméteil D., Roussel F., Ballet J.J. An immunosuppressed rat model for evaluation of anti-Cryptosporidium activity of sinefungin. Folia Parasitol. 41:1994;13-16.
4. Campbell A.T., Robertson L.J., Smith H.V. Viability of Cryptosporidium parvum oocysts: correlation of in vitro excystation with inclusion or exclusion of fluorogenic vital dyes. Appl. Environ. Microbiol. 58:1992;3488-3493.
5. Chaka W., Scharringa J., Verheul A.F.M., Verhoef J., Van Strijp A.G., Hoepelman I.M. Quantitative analysis of phagocytosis and killing of Cryptococcus neoformans by human peripheral blood mononuclear cells by flow cytometry. Clin. Diagn. Lab. Immunol. 2:1995;753-759.
6. Fayer, R., Dubey, J.P., Speer, C.A., 1990. General biology of Cryptosporidium. In: Dubey, J.P., Speer, C.A., Fayer, R. (Eds.), Cryptosporidiosis of Man and Animals. CRC Press, Boca Raton, FL, pp. 1-29.
7. Horan P.K., Kappler J.W. Automated fluorescence analysis for cytotoxicity assays. J. Immunol. 18:1977;309-316.
8. Lemeteil D., Rousel F., Favennec L., Ballet J.J., Brasseur P. Assessment of candidate anticryptosporidial agents in an immunosuppressed rat model. J. Infect. Dis. 167:1993;766-768.
9. Lorenzo M.J., Ares-Mazás M.E., Villacorta I., Duran D. Effect of ultraviolet disinfection of drinking water on the viability of Cryptosporidium parvum oocysts. J. Parasitol. 79:1993;67-70.
10. Luginbuehl A., Pfister K. Cryptosporidiosis of calves as a serious problem on a dairy cattle farm. Swiss Arch. Vet. Med. 138:1996;195-200.
11. Moon H.W., Woode G.N., Ahrens F.A. Attempted chemoprophylaxis of cryptosporidiosis in calves. Vet. Rec. 20:1982;181.
12. Rehg J.E., Hancock M.L., Woodmansee D.B. Characterization of a cyclophosphamide-rat model of cryptosporidiosis. Infect. Immun. 55:1987;2669-2674.
13. Rehg J.E. Anticryptosporidial activity of lasalocid and other ionophorous antibiotics in immunosuppressed rats. J. Infect. Dis. 168:1993;1566-1569.
14. Roberson, E.L., 1982. Antiprotozoan drugs. In: Booth, N.J., McDonald, L.E. (Eds.), Veterinary Pharmacology and Therapeutics, 4th Edition. Iowa State University Press, Ames, IA, pp. 877-878.
15. Sherwood D., Angus K.W., Snodgrass D.R., Tzipori S.T. Experimental cryptosporidiosis in laboratory mice. Infect. Immun. 38:1982;471-475.
16. Varga I., Sréter T., Békési L. Potentiation of ionophorous anticoccidials with duokvin: battery trials against Cryptosporidium baileyi in chickens. J. Parasitol. 81:1995;777-780.
17. Vergara Castiblanco, C.A., 1999. Estudio inmunológico de la cryptosporidiosis humana en Colombia. Thesis, Universidad de Santiago de Compostela, Spain.
18. Xiangdong Y., Schinazi R.F., Arrowood M.J., Lejkowski M., Juodawlkis A.S., Mead J.R. In-vitro activities of paromomycin and lasalocid evaluated in combination against Cryptosporidium parvum. J. Antimicrob. Agents Chemother. 41:1998;293-296.